Skip to content

$IOVA $2 to $14 | Holy Grail of Cancer Therapy

October 6, 2026 · 1 h 29 min

Show notes

Avi Mash hosts Iovance ($IOVA) investor Minnesota Gopher and trader Father of Trades to discuss Iovance's IL-12 tethered TIL program, Amtagvi data in melanoma, non small cell lung cancer, endometrial cancer and sarcoma, FDA CNPV vouchers, a possible Merck buyout, and short selling in biotech. Father of Trades reviews the $IOVA chart and options chain and compares it to $SLS. Minnesota Gopher expects 18 to 22 by year end, and over 30 if a voucher basket is accepted.

This podcast is powered by Scanley, AI visibility for banks and credit unions. Get your 1st month free with code DAILYSTACK at https://meetscanley.com

Taking a BTC loan? Our friends at Ledn are offering .25% off their lowest rates with our link: https://www.ledn.io/partner/dailystack

Chapters:
0:00 Intro music
4:43 Minnesota Gopher on $IOVA and biotech short selling
15:37 IL-12 tethered TIL: holy grail of cancer therapy
22:19 Amtagvi frontline push and Keytruda style expansion
24:54 Biotech lagging the market and AI in medicine
29:06 FDA timelines, China drugs and CNPV vouchers
36:08 Iovance buyout, Merck and global distribution
44:04 Lung, melanoma, endometrial and sarcoma TIL data
56:23 $IOVA chart, volume profile and key levels
1:04:10 $IOVA options chain, open interest and gamma ramp
1:14:45 $IOVA price targets and the $SLS comparison
1:24:21 Father of Trades on BlackBerry QNX and holding winners

Key takeaways:
- Minnesota Gopher calls Iovance's IL-12 tethered TIL a potential holy grail because, in his view, it could turn cold tumors hot and make them treatable.
- Minnesota Gopher cited company figures: a 64.3% response rate in EGFR non small cell lung cancer with Keytruda and a 65.2% response rate in frontline melanoma with Keytruda.
- Minnesota Gopher believes Iovance's new FDA and regulatory hires point to a basket submission for CNPV vouchers in non small cell lung cancer, endometrial cancer and sarcoma, and he named Merck as the likeliest acquirer.
- Father of Trades read the options chain as pinning $IOVA near $14 in the short term and said a move above $20 could set up a gamma squeeze, as he saw in $SLS.
- Father of Trades said scalping profits should be parked in high conviction companies and gains should be protected by taking back cost basis on 10x or 15x winners.

Listen and follow The Daily Stack:
Spotify: https://open.spotify.com/show/0JQzqfVmkKiXuwSA6hyoDs
Apple Podcasts: https://podcasts.apple.com/us/podcast/the-daily-stack/id1831884653
Website: https://dailystackhq.com
X: https://x.com/dailystackHQ

Not financial advice.

All episodes of The Daily Stack

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.